tiprankstipranks
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
Holding STRO?
Track your performance easily

Sutro Biopharma (STRO) Financial Statements

583 Followers

Sutro Biopharma Financial Overview

Sutro Biopharma's market cap is currently ―. The company's EPS TTM is $-1.623; its P/E ratio is -1.63; Sutro Biopharma is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 8.52M$ 25.71M$ 13.01M$ 113.72M$ 16.92M
Gross Profit$ 8.52M$ 25.71M$ 13.01M$ 113.72M$ 16.92M
EBIT$ -48.79M$ -48.01M$ -48.82M$ 55.60M$ -38.77M
EBITDA$ -46.99M$ -43.56M$ -47.05M$ 57.34M$ -37.03M
Net Income Common Stockholders$ -48.79M$ -48.02M$ -58.21M$ 31.07M$ -49.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 388.25M$ 425.99M$ 313.22M$ 375.62M$ 355.15M
Total Assets$ 451.83M$ 489.04M$ 403.40M$ 470.74M$ 431.73M
Total Debt$ 24.86M$ 26.53M$ 28.07M$ 33.63M$ 38.17M
Net Debt$ -363.39M$ -399.47M$ -285.15M$ -341.98M$ -316.98M
Total Liabilities$ 340.61M$ 336.87M$ 305.38M$ 321.09M$ 319.39M
Stockholders Equity$ 111.22M$ 152.18M$ 98.05M$ 149.65M$ 112.35M
Cash Flow-
Free Cash Flow$ -64.52M$ 9.46M$ -64.74M$ 12.63M$ -33.83M
Operating Cash Flow$ -64.52M$ 9.46M$ -64.74M$ 14.07M$ -33.50M
Investing Cash Flow$ 147.29M$ -80.38M$ 64.11M$ -23.51M$ -114.02M
Financing Cash Flow$ 1.02M$ 96.49M$ -3.43M$ -3.13M$ -5.74M
Currency in USD

Sutro Biopharma Earnings and Revenue History

Sutro Biopharma Debt to Assets

Sutro Biopharma Cash Flow

Sutro Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis